Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 Treatment of Recurrent Herpes Labialis

NCT01695187 is registered in ClinicalTrials.gov with NanoBio Corporation as lead sponsor.

NCT NCT01695187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 Treatment of Recurrent Herpes Labialis
Lead sponsor
NanoBio Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2012
Completion date
July 31, 2013
Enrollment
362 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis